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We read with interest the study by Fazekas and colleagues 
demonstrating that lower levels of carboxyhemoglobin 
are associated with increased mortality in critically ill 
patients [1]. Th is observation is of interest since prior 
studies have shown that carbon monoxide (CO), the 
silent killer, may actually have therapeutic applications. 
CO suppresses inﬂ ammation and apoptosis, reduces 
pulmonary hypertension and potentially protects against 
multiple organ injury in animal models [2]. Th e fact that 
average carboxyhemoglobin levels are slightly lower in 
ICU nonsurvivors compared with survivors (1.5% vs. 
1.6%, P = 0.003) supports the ﬁ ndings of animal studies.
However, an important confounding factor deserves 
consideration. ICU nonsurvivors are sicker and therefore 
likely to receive a higher FiO2 than ICU survivors. Most 
hospitals supply oxygen from liquid oxygen, whereas 
medical air is supplied by compressing ﬁ ltered environ-
mental air. Previous work at Pittsburgh has shown that 
nitric oxide (NO) contamination of compression medical 
air resulted in a clinically detectable diﬀ erence in NO 
levels that directly altered oxygenation [3]. Th e air in 
most major cities is also contaminated with CO [4] 
consequent to fossil fuel combustion. Medical air thus 
contains varying amounts of CO, as well as other 
pollutants. Patients receiving a higher FiO2 receive less 
medical air, and are therefore exposed to less occult CO. 
Th is reduction in medical air might explain the small 
diﬀ erences in carboxyhemoglobin seen in the present 
study, just as it explained the lower NO levels. Until this 
confounding inﬂ uence is accounted for, the prior 
observations may merely reﬂ ect this CO washout 
phenomenon.
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We kindly thank Cove and Pinsky for their reply to our 
study. Based on the CO content of medical air and 
oxygen, they provide a potential explanation for the 
observed diﬀ erences in carboxyhemoglobin levels in ICU 
survivors and nonsurvivors described in our study. We 
regret that the absence of data on the FiO2 fractions used 
in our study population does not enable us to further test 
the relation between the amount of oxygen used and 
carboxyhemoglobin levels.
Sheu and colleagues found an increased activity of the 
heme oxygenase-1 gene to be associated with a reduced 
risk for the development of adult respiratory distress 
syndrome [5]. Th is ﬁ nding leads us to assume that there 
is – at least in part – a genetic basis to the diﬀ erences in 
carboxy hemoglobin levels and mortality. Furthermore, 
Melley and colleagues found elevated maximum 
carboxyhemo globin levels to be associated with an 
increased mortality in critically ill patients following 
cardiothoracic surgery [6] – which would potentially 
argue against the hypo the sis by Cove and Pinsky. Of note, 
however, this ﬁ nding was not reproduced in our study.
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